Evaluation of immune parameters and lymphocyte production of prolactin-immunoreactive proteins after chronic administration of cocaine to pregnant rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 2, 1996, Pages 1090-1096

  Masten, Scott A ^a   Millard, William J ^a   Karlix, Janet L ^a   Shiverick, Kathleen T ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; PROLACTIN;

ANIMAL EXPERIMENT; ARTICLE; DRUG ABUSE; DRUG EFFECT; FEMALE; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RAT;

ANIMALS; BODY WEIGHT; COCAINE; FEMALE; IMMUNITY; IMMUNOGLOBULIN G; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; LYMPHOID TISSUE; MOLECULAR WEIGHT; PREGNANCY; PREGNANCY, ANIMAL; PROLACTIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030435330     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. ANTHONY, J. C., VLAHOV, D., NELSON, K. E., COHN, S., ASTEMBORSKI, J. AND SOLOMON, L.: New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am. J. Epidemiol. 134: 1175-1189, 1991.
2. BAGASRA, O. AND FORMAN, L.: Functional analysis of lymphocytes subpopulations in experimental cocaine abuse. I. Dose-dependent activation of lymphocyte subsets. Clin. Exp. Immunol. 77: 289-293, 1989.
3. BERKELEY, M. B., DAUSSIN, S., HERNANDEZ, M. C. AND BAYER, B M.: In vitro effects of cocaine, lidocaine, and monoamine uptake inhibitors on lymphocyte proliferative responses. Immunopharmacol. Immunotoxicol. 16: 165-178, 1994.
4. BINGOL, N., FUCHS, M., DIAZ, V., STONE, R. K. AND GROMISCH, D. S.: Teratogenicity of cocaine in humans. J. Pediatrics 110: 93-96, 1987.
5. BRADFORD, M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
6. BREIER, B. H., GALLAHER, B. W. AND GLUCKMAN, P. D.: Radioimmunoassay for insulin-like growth factor-1: Solutions to some potential problems and pitfalls. J. Endocrinol. 128: 347-357, 1991.
7. CARLSSON, L., EDEN, S. AND JASSSON, J.-O.: The plasma pattern of growth hormone in conscious rats during late pregnancy. J. Endocrinol. 124: 191-198, 1990.
8. CHASNOFF, I. J., GRIFFITH, D. R., FREIER, C. AND MURRAY, J.: Cocaine/polydrug use in pregnancy: Two year followup. Pediatrics 89: 284-289, 1992.
9. CLARKE, A. G., GIL, A. L., AND KENDALL, M. D.: The effects of pregnancy on the mouse thymic epithelium. Cell Tissue Res. 275: 309-318, 1994.
10. COICO, R., COIGAN, J. E., KRUISBEEK, A. M., MARQUILES, D. M., SHEVACH, E. M. AND STROBER, W., EDS.: Current Protocols in Immunology. Greene Publishing and Wiley Interscience, New York, 1992.
11. CONE, E. J., KUMOR, K., THOMPSON, L. K. AND SHERER, M.: Correlation of saliva cocaine levels with plasma levels and with pharmacologic effects after intravenous cocaine administration in human subjects. J. Anal. Toxicol. 12: 200-206, 1988.
12. DAUGHADAY, W. H., KAPADIA, M. AND MARIZ, I.: Serum somatomedin binding proteins: Physiologic significance and interference in radioligand assay. J. Lab. Clin. Med. 109: 355-363, 1987.
13. DAVENPORT, M. L., CLEMMONS, D. R., MILES, M. V., CAMACHO-HUBNER, C., D'ERCOLE, A. J. AND UNDERWOOD, L. E.: Regulation of serum insulin-like growth factor-1 (IGF-1) and IGF binding proteins during rat pregnancy. Endocrinology 127: 1278-1286, 1990.
14. DI FRANCESCO, P., PICA, F., MARINI, S., FAVALLI, C., AND GARACI, E.: Thymosin alpha one restores murine T-cell-mediated responses inhibited by in vivo cocaine administration. Int. J. Immunopharmacol. 14: 1-9, 1992.
15. DOW-EDWARDS, D. L.: Cocaine effects on fetal development: A comparison of clinical and animal research findings. Neurotoxicol. Teratol. 13: 347-352, 1991.
16. FAITH, R. E. AND VALENTINE, J. L.: Effects of cocaine exposure on immune function. Toxicologist 3: 56, 1983.
17. GALA, R. R.: Prolactin and growth hormone in the regulation of the immune system. Proc. Soc. Exp. Biol. Med. 198: 513-527, 1991.
18. GILLIS, S., FERM, M. M., OU, W. AND SMITH, K. A.: T cell growth factor: Parameters of production and a quantitative microassay for activity. J. Immunol. 120: 2027-2032, 1978.
19. GRATTAN, D. R. AND AVERILL, R. L. W.: Effect of ovarian steroids on a nocturnal surge of prolactin secretion that precedes parturition in the rat. Endocrinology 126: 1199-1205, 1990.
20. HANDLER, A., KISTIN, N., DAVIS, F. AND FERRE, C : Cocaine use during pregnancy: Perinatal outcomes Am. J. Epidemiol. 133: 818-825, 1991.
21. HARTMANN, D. P., HOLADAY, J. W. AND BERNTON, E. W.: Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB J. 3: 2194-2202, 1989.
22. HAVAS, H. F., DELLARIA, M , SCHIFFMAN, G., GELLER, E. B. AND ADLER, M. W.: Effect of cocaine on the immune response and host resistance in BALB/c mice. Int. Archs. Allergy Appl. Immunol. 83: 377-383, 1987.
23. HOLSAPPLE, M. P., AND MUNSON, A. E.: Immunotoxicology of abused drugs. In Immunotoxicology and Immunopharmacology, ed by J. H. Dean, M. I. Luster, A. E. Munson and H. Amos, pp. 381-392, Raven Press, New York, 1985.
24. HOWARD, H. L., MCLAUGHLIN-TAYLOR, E AND HILL, R. L.: The effect of mouse euthanasia technique on subsequent lymphocyte proliferation and cell-mediated lympholysis assays. Lab. Animal Sci 40: 510-514, 1990.
25. KELLEY, K. W., ARKINS, S. AND LI, Y. M.: Growth hormone, prolactin, and insulin-like growth factors: New jobs for old players. Brain Behav. Immunity 6: 317-326, 1992.
26. KENNER, J. R., HOLADAY, J. W., BERNTON, E. W. AND SMITH, P. F.: Prolactin-like protein in murine splenocytes: Morphological and biochemical evidence. Prog. Neuro-EndocrinImmunol. 3: 188-195, 1990.
27. KLEIN, T. W., MATSUI, K., NEWTON, C. A., YOUNG, J , WIDEN, R. E. AND FRIEDMAN, H.: Cocaine suppresses proliferation of phytohemagglutinin-activated human peripheral blood T-cells. Int. J. Immunopharmacol 15: 77-86, 1993.
28. KLEIN, T. W., NEWTON, C. A. AND FRIEDMAN, H.: Suppression of human and mouse lymphocyte proliferation by cocaine. In Psychological, Neuropsychiatric, and Substance Abuse Aspects of AIDS, ed. by T. P. Bridge, A. F. Marsky and F. K. Goodwin, pp. 139-143, Raven Press, New York, 1988.
29. LAEMMLI, U. K.: Cleavage of structural proteins during assembly of the head of bacteriophage T4 Nature (Lond.) 227: 680-685, 1970.
30. LAHAT, N., MILLER, A., SHTILLER, R. AND TOUBY, E.: Differential effects of prolactin upon activation and differentiation of human B lymphocytes. J. Neuroimmunol. 47: 35-40, 1993.
31. LEGRUE, S. J. AND MUNN, C. G.: Comparison of the immuno-suppressive effects of cyclosporin, lipid-soluble anesthetics, and calmodulin antagonists. Response to interleukin-2. Transplantation 42; 679-685, 1986.
32. LOPER, K. A.: Clinical toxicology of cocaine. Med. Toxicol. Adverse Drug Exp. 4: 174-185, 1989.
33. MATERA, L., CESANO, A., MUCCIOLI, G AND VEGLIA, F.: Modulatory effect of prolactin on the DNA synthesis rate and NK activity of large granular lymphocytes. Int. J. Neurosci. 51: 265-267, 1990.
34. MATSUI, K., FRIEDMAN, H. AND KLEIN, T. W.: Cocaine augments proliferation of human peripheral blood T-lymphocytes activated with anti-CD3 antibody. Int. J. Immunopharmacol. 14: 1213-1220, 1992.
35. MCLEAN, J. M., MOSLEY, J. G. AND GIBBS, A. C. C.: Changes in the thymus, spleen, and lymph nodes during pregnancy and lactation in the rat. J. Anat. 118: 223-229, 1974.
36. MEDINA, K. L., SMITHSON, G. AND KINCADE, P. W.: Suppression of B lymphopoeisis during normal pregnancy. J. Exp. Med. 178: 1507-1515, 1993.
37. MENDELSON, J. H., MELLO, N. K., TEOH, S. K., ELLINGBOE, J. AND COCHIN, J.: Cocaine effects on pulsatile secretion of anterior pituitary, gonadal, and adrenal hormones. J. Clin. Endocrinol. Metab. 69: 1256-1260, 1989.
38. MONTGOMERY, D. W., LEFEVRE, J. A., ULRICH, E. D., ADAMSON, C. R. AND ZUKOSKI, C. F.: Identification of prolactin-like proteins synthesized by normal murine lymphocytes. Endocrinol. 127: 2601-2603, 1990.
39. OU, D. W., SHEN, M-L. AND LUO, Y-D.: Effects of cocaine on the immune system of Balb/C mice. Clin. Immunol. Immunopathol. 52: 305-312, 1989.
40. PHILLIPS, D. L., TEBBETT, I. R., MASTEN, S. A. AND SHIVERICK, K. T.: Stimulatory effects of cocaine and its metabolites on IM-9 human B lymphoblastoid cells. Int. J. Immunopharmacol. 17: 57-63, 1995.
41. PIROZHKOV, S. V., WATSON, R. R. AND CHEN, G. -J.: Ethanol enhances immunosuppression induced by cocaine. Alcohol 9: 489-494, 1992.
42. REIMER, C. B., BLACK, C. M., HOLMAN, R. C., WELLS, T. W., RAMIREZ, R. M., SA-FERREIRA, J. A., NICHOLSON, J. K. A. AND MCDOUGAL, J. S.: Hypergammaglobulinemia associated with human immunodeficiency virus infection. Monographs Allergy 23: 83-96, 1988.
43. RICHTER, R. W.: Infections other than AIDS. Neurol. Clinics 11: 591-603, 1993.
44. ROBERTS, S. M., JAMES, R. C. AND HARBISON, R. D.: Cocaine-induced hepatotoxicity. In Cocaine: Pharmacology, Physiology, and Clinical Strategies, ed. by J. M. Lakoski, M. P. Galloway and F. J. White, pp. 15-33. CRC Press, Boca Raton, FL, 1992.
45. RUIZ, P., CLEARY, T., NASSIRI, M. AND STEELE, B.: Human T lymphocyte subpopulation and NK cell alterations in persons exposed to cocaine. Clin. Immunol. Immunopathol. 70: 245-250, 1994.
46. SALHAB, A. S., DEVANE, C. L., MEDRANO, T., BUHI, W. C., TEBBETT, I. R. AND SHIVERICK, K. T.: Fetoplacental growth and placental protein synthesis in rats after chronic maternal cocaine administration. J. Pharmacol. Exp. Ther. 270: 392-398, 1994.
47. SHAH, G. N., LAIRD, H. E., III AND RUSSELL, D. H.: Identification and characterization of a prolactin-like polypeptide synthesized by mitogen-stimulated murine lymphocytes. Int. Immunol. 3: 297-304, 1991
48. SINGH, M., MILLARD, W. J., LAYDEN, M. P , ROMANO, T M. AND SIMPKINS, J. W.: Opiate stimulation of prolactin secretion is reversed by ovarian hormone treatment. Neuroendocrinology 56: 195-203, 1992a.
49. SINCH, M., SIMPKINS, J. W., LAYDEN, M. P., ROMANO, T. M. AND MILLARD, W. J.: Opiate modulation of growth hormone secretion is compromised during the steroid-induced luteinizing hormone surge. Neuroendocrinology 55: 214-220, 1992b.
50. SMIALOWICZ, R. J., RIDDLE, M. M., WILLIAMS, W. C , COPELAND, C. B., LEUBKE, R. W. AND ANDREWS, D. L.: Differences between mice and rats in the immunosuppressive activity of 2-methoxyethanol and 2-methoxyacetic acid. Toxicology 74: 57-67, 1992.
51. SMIALOWICZ, R. J., RIDDLE, M. M., WILLIAMS, W. C. AND DILBERTO, J. J.: Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity and lymphocyte subpopulations: Differences between mice and rats. Toxicol. Appl. Pharmacol. 124: 248-286, 1994.
52. SOBRIAN, S. K., BURTON, L. E., ROBINSON, N. L., ASHE, W. K., HUTCHINSON, J., STOKES, D. L. AND TURNER, L. M.: Neurobehavioral and immunological effects of prenatal cocaine exposure in rat. Pharmacol. Biochem. Behav. 35: 617-629, 1990
53. TEBBETT, I. R. AND KARLIX, J. L.: Effects of cocaine on the immune response. In Methods in Neuroscience, ed. by M. I. Phillips and D. Evans, pp. 389-408 Academic Press, New York, 1994.
54. VAN DE KAR, L. D.: Neuroendocrine effects of cocaine. In Cocaine: Pharmacology, Physiology, and Clinical Strategies, ed. by J. M. Lakoski, M. P. Galloway, and F. J. White, pp. 341-352. CRC Press, Boca Raton, FL, 1992.
55. VISELLI, S. M., STANEK, E. M , MUKHERJEE, P., HYMER, W. C. AND MASTRO, A. M. Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats. Endocrinology 129: 983-990, 1991.